title: In parkinsonian substantia nigra, alpha-synuclein is modified by acrolein, a lipid-peroxidation product, and accumulates in the dopamine neurons with inhibition of proteasome activity.
abstract: alpha-Synuclein (alphaSYN) plays a central role in the neural degeneration of Parkinson's disease (PD) through its conformational change. In PD, alphaSYN, released from the membrane, accumulates in the cytoplasm and forms Lewy body. However, the mechanism behind the translocation and conformational change of alphaSYN leading to the cell death has not been well elucidated. This paper reports that in the dopamine neurons of the substantia nigra containing neuromelanin from PD patients, alphaSYN was modified with acrolein (ACR), an aldehyde product of lipid peroxidation. Histopathological observation confirmed the co-localization of protein immunoreactive to anti-alphaSYN and ACR antibody. By Western blot analyses of samples precipitated with either anti-alphaSYN or anti-ACR antibody, increase in ACR-modified alphaSYN was confirmed in PD brain. Modification of recombinant alphaSYN by ACR enhanced its oligomerization, and at higher ACR concentrations alphaSYN was fragmented and polymerized forming a smear pattern in SDS-PAGE. ACR reduced 20S proteasome activity through the direct modification of the proteasome proteins and the production of polymerized ACR-modified proteins, which inhibited proteasome activity in vitro. These results suggest that ACR may initiate vicious cycle of modification and aggregation of proteins, including alphaSYN, and impaired proteolysis system, to cause neuronal death in PD.
authors: National Center for Geriatrics and Gerontology, Department of Geriatric Medicine, Obu, Aichi, Japan.
authors: M
authors: M
authors: Shamoto-Nagai
authors: W
authors: W
authors: Maruyama
authors: Y
authors: Y
authors: Hashizume
authors: M
authors: M
authors: Yoshida
authors: T
authors: T
authors: Osawa
authors: P
authors: P
authors: Riederer
authors: M
authors: M
authors: Naoi
mesh_terms: D000171:Acrolein / Q000378:metabolism*; D000368:Aged; D015153:Blotting, Western; D004298:Dopamine / Q000378:metabolism; D004591:Electrophoresis, Polyacrylamide Gel; D005260:Female; D006801:Humans; D015227:Lipid Peroxidation / Q000502:physiology; D008297:Male; D008543:Melanins / Q000378:metabolism; D009474:Neurons / Q000378:metabolism* / Q000473:pathology; D010300:Parkinson Disease / Q000378:metabolism*; D046988:Proteasome Endopeptidase Complex / Q000378:metabolism*; D013378:Substantia Nigra / Q000378:metabolism* / Q000473:pathology; D051844:alpha-Synuclein / Q000378:metabolism*
chemical_list: D008543:Melanins; D051844:alpha-Synuclein; C014121:neuromelanin; D000171:Acrolein; D046988:Proteasome Endopeptidase Complex; D004298:Dopamine
references: Mol Pharmacol. 2004 Mar;65(3):655-64
references: 14978244
references: Neurotoxicology. 2002 Oct;23(4-5):553-67
references: 12428728
references: J Neurosci. 2000 Sep 1;20(17):6365-73
references: 10964942
references: Nat Med. 2002 Jun;8(6):600-6
references: 12042811
references: J Mol Neurosci. 2004;23(1-2):23-34
references: 15126689
references: Eur J Biochem. 2004 Aug;271(15):3180-9
references: 15265037
references: Nat Genet. 1998 Feb;18(2):106-8
references: 9462735
references: J Biol Chem. 2002 Aug 2;277(31):27919-26
references: 12032148
references: J Biol Chem. 2002 Dec 13;277(50):48976-83
references: 12351642
references: Neurosci Lett. 2001 Jan 19;297(3):191-4
references: 11137760
references: J Mol Biol. 2001 Apr 6;307(4):1061-73
references: 11286556
references: Mutat Res. 1990 May;238(3):223-33
references: 2342513
references: J Biol Chem. 2003 Oct 10;278(41):40186-97
references: 12885775
references: Biochemistry. 2001 Jul 3;40(26):7812-9
references: 11425308
references: Nature. 1998 Apr 9;392(6676):605-8
references: 9560156
references: J Neurosci. 2004 Jul 28;24(30):6715-23
references: 15282274
references: Science. 2000 Feb 18;287(5456):1265-9
references: 10678833
references: Ann N Y Acad Sci. 2000;924:62-7
references: 11193803
references: J Biol Chem. 2004 May 21;279(21):21966-75
references: 15028717
references: J Biol Chem. 2000 Nov 3;275(44):34328-34
references: 10915790
references: Science. 1997 Jun 27;276(5321):2045-7
references: 9197268
references: Science. 2003 Oct 31;302(5646):841
references: 14593171
references: J Neurosci Res. 2003 Nov 15;74(4):589-97
references: 14598303
references: J Neurochem. 1999 Feb;72 (2):751-6
references: 9930749
references: Ann Neurol. 2004 Feb;55(2):164-73
references: 14755719
references: Proc Natl Acad Sci U S A. 1996 Apr 2;93(7):2696-701
references: 8610103
references: J Neuropathol Exp Neurol. 1998 Apr;57(4):334-7
references: 9600226
references: Nature. 1998 Oct 1 ;395(6701):451-2
references: 9774100
references: Biochemistry. 2003 Jan 28;42(3):672-8
references: 12534279
references: Nature. 1997 Aug 28;388(6645):839-40
references: 9278044
references: Nature. 2000 Mar 23;404(6776):394-8
references: 10746727
references: Nat Cell Biol. 2002 Feb;4(2):160-4
references: 11813001
references: Biochem J. 2006 Jan 1;393(Pt 1):343-9
references: 16146428
references: Proc Natl Acad Sci U S A. 1998 Apr 28;95(9):4882-7
references: 9560197
references: J Biol Chem. 2003 Jan 3;278(1):311-8
references: 12401807
references: Science. 2000 Nov 3;290(5493):985-9
references: 11062131
references: Neuron. 2002 Dec 19;36(6):1007-19
references: 12495618
references: J Neurosci Res. 1999 Oct 1;58(1):120-9
references: 10491577
references: Am J Pathol. 2000 Nov;157(5):1439-45
references: 11073803